12.01.2013 Views

ischaemic preconditioning of the human heart. - Leicester Research ...

ischaemic preconditioning of the human heart. - Leicester Research ...

ischaemic preconditioning of the human heart. - Leicester Research ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

3.1 INTRODUCTION:<br />

Brief periods <strong>of</strong> ischaerma and reperfusion appear to protect <strong>the</strong> myocardium from a subsequent<br />

lethal <strong>ischaemic</strong> injury. This phenomenon <strong>of</strong> ischaernic <strong>preconditioning</strong>, originally described by<br />

Reimer et al , 1986 [2521, has been shown to exist in all animal species studied to date. There is<br />

now compelling evidence that it exists in <strong>human</strong>s. This evidence arises from in-vitro experiments<br />

with <strong>human</strong> atrial trabeculae[3251, ventricular trabeculae [521 and cultured ventricular<br />

myocytesf 1401, studies <strong>of</strong> patients undergoing planned procedures which invariably involve brief<br />

periods <strong>of</strong> ischernia such as percutaneous transluminal coronary angioplasty [781and coronary<br />

bypass graft surgery[346]. Despite <strong>the</strong> wealth <strong>of</strong> information generated by <strong>the</strong>se <strong>human</strong> studies,<br />

<strong>the</strong> most effective ischemic <strong>preconditioning</strong> protocol in man remains unknown.<br />

In rats, rabbits, dogs and pigs, separation <strong>of</strong> <strong>the</strong> brief <strong>preconditioning</strong> Ischernic episodes from <strong>the</strong><br />

long occlusion by 60 to 120 min results in complete or nearly complete loss <strong>of</strong> protection.<br />

However, if <strong>the</strong> duration <strong>of</strong> this separation is extended to 24 to 72 hr, <strong>the</strong> infarct size will be<br />

reduced again. Hence <strong>the</strong>re appears to be a distinct first (early) as well as a second (delayed)<br />

phase <strong>of</strong> protection, There is no evidence that this biphasic mode <strong>of</strong> protection exists<br />

in <strong>human</strong>s.<br />

Although studies during angioplasty have given evidence for ischaernic <strong>preconditioning</strong> in man,<br />

clearly <strong>the</strong>re are practical and ethical limitations on <strong>the</strong> extent to which such situations can be<br />

used to investigate <strong>the</strong> characteristics <strong>of</strong> <strong>preconditioning</strong> in <strong>the</strong> <strong>human</strong> myocardium. In contrast, in<br />

vilro preparations, allow a wide range <strong>of</strong> experimental manipulations. The aims <strong>of</strong> <strong>the</strong> studies in<br />

this chapter were to investigate <strong>the</strong> most effective <strong>preconditioning</strong> protocol in <strong>human</strong> mvocardium<br />

and also <strong>the</strong> existence and potency <strong>of</strong> a second window <strong>of</strong> protection. To achieve this, I subjected<br />

to simulated ischaemia isolated, right atrial trabeculae slices obtained from patients undergoing<br />

elective cardiac surgery.<br />

67

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!